Olimel N9

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin, the active ingredient in Olimel N9, is a mixture of essential and non‑essential amino acids presented as a sterile powder for intravenous use. It supports metabolic functions and protein synthesis in patients requiring nutritional supplementation.

GNH USA supplies Olimel N9 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Olimel N9 provides amino acid supplementation for conditions where protein turnover is increased or intake is insufficient. - Post‑operative recovery: helps maintain nitrogen balance during wound healing. - Severe trauma or burns: supports tissue repair and metabolic demand. - Chronic renal failure on dialysis: supplies essential amino acids lost during treatment. - Malnutrition in elderly patients: assists in preserving lean body mass. - Critical illness in intensive care: contributes to overall nutritional support. - Inborn errors of metabolism: provides specific amino acids required for metabolic pathways.

Amino acid solutions are generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Mild nausea or vomiting. - Transient flushing or warmth sensation. - Mild headache. - Slight increase in serum urea nitrogen. - Local irritation at the infusion site. - Temporary rise in blood glucose.

Serious or Rare Side Effects: - Anaphylactic or severe hypersensitivity reaction. - Hyperammonemia leading to neurological symptoms. - Metabolic acidosis. - Severe electrolyte disturbances. - Acute renal impairment. - Pulmonary edema in fluid‑overloaded patients.

When using Olimel N9, clinicians should consider patient‑specific factors and monitor relevant parameters. - Renal function: assess baseline creatinine and adjust infusion volume. - Hepatic function: monitor for signs of ammonia accumulation. - Fluid balance: avoid overload in patients with heart failure. - Electrolyte status: check serum electrolytes before and during therapy. - Pregnancy and lactation: weigh potential benefits against unknown risks. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Amino acid preparations can interact with certain medications and clinical conditions.

Major Interactions (Avoid): - High‑dose levodopa: may compete for transport across the blood‑brain barrier. - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Certain antibiotics (e.g., tetracyclines): reduced absorption when given concurrently.

Moderate Interactions (Monitor Closely): - Insulin or oral hypoglycemics: may enhance glucose‑lowering effect. - Loop diuretics: potential for electrolyte shifts. - Warfarin: possible alteration of INR values. - Corticosteroids: increased protein catabolism may modify amino acid needs.